STAT Plus: FDA urged to heighten safety warnings on common type 2 diabetes drugs
ANDREW HARNIK/AP
A consumer advocacy group is urging the FDA to heighten safety warnings about a widely prescribed group of type 2 diabetes drugs.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario